Screening of Differentially Expressed Genes in Rat Synovitis by Transcriptome Sequencing and in Vitro Verification of Therapeutic Target of Fraxetin

doi:10.12300/j.issn.1674-5817.2022.100

Abstract

Abstract:

Objective Using transcriptome sequencing to screen the differentially expressed genes between the synovial tissue of rats with knee osteoarthritis (KOA) induced by monosodium iodoacetate (MIA) and that of normal rats, and then screen the target of fraxetin in the treatment of synovitis. Methods SD rats were divided into KOA group and the negative control (NC) group. Rat right knee KOA model was prepared by MIA knee joint injection in KOA group and none treatments in NC group. Four weeks after modeling, the right knee synovial tissue of rats in each group was taken for transcriptome sequencing. Then the differential gene expression analysis, GO enrichment analysis, KEGG function enrichment analysis and PPI protein network interaction analysis were performed. The synovial macrophage Raw264.7 cells were divided into the control group, lipopolysaccharide (LPS) intervention group and LPS+60 μmol/L fraxetin intervention group, then RNA-sequencing results were verified by qRT-PCR in the three groups. Results The results of differential gene-expression analysis showed that there were 1 730 up-regulated genes and 1 546 down-regulated genes in the KOA group compared with the control group, among which the significantly up-regulated genes were mmp12, Acod1, Acan, Col2a1, Atp6v0d2 (|log2(FoldChange)|≥1, adjusted P<0.01). KEGG cluster analysis and GO cluster analysis showed that differential genes were mainly involved in the regulation of inflammation and immune metabolism, such as tricarboxylic acid cycle and mitochondrial function. The expressions of Acod1 and Atp6v0d2 in Raw264.7 cells after LPS intervention were significantly higher. Compared with the LPS intervention group, the expression level of Atp6v0d2 in Raw264.7 cells after LPS+fraxetin combined intervention was significantly lower. Conclusion After modeling KOA induced by MIA, macrophage-related genes mmp12, Acod1 and Atp6v0D2, which mediate inflammation and immune metabolism, were highly expressed in the synovial tissue of rats, suggesting that there might be immune metabolism changes mediated by synovial macrophages during the occurrence and development of KOA. The increased expression of Acod1 and Atp6v0d2 in macrophages Raw264.7 after LPS intervention can preliminarily confirm this result. Among them, Atp6v0d2 may be a potential target of fraxetin in the treatment of synovitis, which provides a new idea for KOA treatment.

Key words: Osteoarthritis, Transcriptome sequencing, Immunometabolism, Synovial macrophage, Fraxetin

CLC Number:

Q95-33

Ling YANG,Di ZHUANG,Lilun JIN. Screening of Differentially Expressed Genes in Rat Synovitis by Transcriptome Sequencing and in Vitro Verification of Therapeutic Target of Fraxetin[J]. Laboratory Animal and Comparative Medicine, 2023, 43(1): 11-20. DOI: 10.12300/j.issn.1674-5817.2022.100.

Figures/Tables 6

References 24

1	VINA E R, KWOH C K. Epidemiology of osteoarthritis: literature update[J]. Curr Opin Rheumatol, 2018, 30(2):160-167. DOI: 10.1097/BOR.0000000000000479 .
2	ABRAMOFF B, CALDERA F E. Osteoarthritis: pathology, diagnosis, and treatment options[J]. Med Clin North Am, 2020, 104(2):293-311. DOI: 10.1016/j.mcna.2019.10.007 .
3	EYMARD F, PIGENET A, CITADELLE D, et al. Knee and hip intra-articular adipose tissues (IAATs) compared with autologous subcutaneous adipose tissue: a specific phenotype for a central player in osteoarthritis[J]. Ann Rheum Dis, 2017, 76(6):1142-1148. DOI: 10.1136/annrheumdis-2016-210478 .
4	NEOGI T, GUERMAZI A, ROEMER F, et al. Association of joint inflammation with pain sensitization in knee osteoarthritis: the multicenter osteoarthritis study[J]. Arthritis Rheumatol, 2016, 68(3):654-661. DOI: 10.1002/art.39488 .
5	KEMBLE S, CROFT A P. Critical role of synovial tissue-resident macrophage and fibroblast subsets in the persistence of joint inflammation[J]. Front Immunol, 2021, 12:715894. DOI: 10.3389/fimmu.2021.715894 .
6	LOPES E B P, FILIBERTI A, HUSAIN S ALI, et al. Immune contributions to osteoarthritis[J]. Curr Osteoporos Rep, 2017, 15(6):593-600. DOI: 10.1007/s11914-017-0411-y .
7	马振源, 莫蕙. 中医贴敷治疗膝骨关节炎的研究进展[J]. 南京中医药大学学报, 2020, 36(6):926-930. DOI: 10.14148/j.issn.1672-0482.2020.0926 .
	MA Z Y, MO H. Research progress of traditional Chinese medicine sticking therapy in the treatment of knee osteoarthritis[J]. J Nanjing Univ Tradit Chin Med, 2020, 36(6):926-930. DOI: 10.14148/j.issn.1672-0482.2020.0926 .
8	侯成志, 李秋月, 魏戌, 等. 独活寄生汤治疗膝骨关节炎的研究[J]. 中国中医基础医学杂志, 2021, 27(11):1843-1846. DOI: 10.19945/j.cnki.issn.1006-3250.2021.11.036 .
	HOU C Z, LI Q Y, WEI X, et al. Study on Duhuo Jisheng Decoction in the treatment of knee osteoarthritis[J]. J Basic Chin Med, 2021, 27(11):1843-1846. DOI: 10.19945/j.cnki.issn.1006-3250.2021.11.036 .
9	王倩, 杨凯, 马强, 等. 中医药治疗膝骨关节炎研究进展[J]. 陕西中医药大学学报, 2022, 45(3):130-134. DOI: 10.13424/j.cnki.jsctcm.2022.03.029 .
	WANG Q, YANG K, MA Q, et al. Research progress on treatment of knee osteoarthritis with traditional Chinese medicine[J]. J Shaanxi Univ Chin Med, 2022, 45(3):130-134. DOI: 10.13424/j.cnki.jsctcm.2022.03.029 .
10	HUSSAIN S M, NEILLY D W, BALIGA S, et al. Knee osteoarthritis: a review of management options[J]. Scott Med J, 2016, 61(1):7-16. DOI: 10.1177/0036933015619588 .
11	WANG Q, ZHUANG D, FENG W, et al. Fraxetin inhibits interleukin-1β-induced apoptosis, inflammation, and matrix degradation in chondrocytes and protects rat cartilage in vivo [J]. Saudi Pharm J, 2020, 28(12):1499-1506. DOI: 10.1016/j.jsps.2020.09.016 .
12	金灵璐, 朱尉东, 仲卫红, 等. 升麻素苷治疗膝骨关节炎的作用机制研究[J]. 风湿病与关节炎, 2021, 10(12):45-48.
	JIN L L, ZHU W D, ZHONG W H, et al. On the mechanism of cimicifugin in the treatment of knee osteoarthritis[J]. Rheum Arthritis, 2021, 10(12):45-48.
13	高嘉美, 潘赐明, 郗域江, 等. 当归治疗骨关节炎作用机制的研究进展[J]. 风湿病与关节炎, 2021, 10(11):77-80.
	GAO J M, PAN C M, XI Y J, et al. Research progress on the mechanism of Angelica sinensis in the treatment of osteoarthritis[J]. Rheum Arthritis, 2021, 10(11):77-80.
14	DESHMUKH V, O'GREEN A L, BOSSARD C, et al. Modulation of the Wnt pathway through inhibition of CLK2 and DYRK1A by lorecivivint as a novel, potentially disease-modifying approach for knee osteoarthritis treatment[J]. Osteoarthritis Cartilage, 2019, 27(9): 1347-1360. DOI: 10.1016/j.joca.2019. 05. 006 .
15	LI Z H, HUANG Z Y, ZHANG H, et al. P2X7 receptor induces pyroptotic inflammation and cartilage degradation in osteoarthritis via NF-κB/NLRP3 crosstalk[J]. Oxidative Med Cell Longev, 2021, 2021:1-16. DOI: 10.1155/2021/8868361 .
16	ZHENG L L, ZHANG Z J, SHENG P Y, et al. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis[J]. Ageing Res Rev, 2021, 66: 101249. DOI: 10.1016/j.arr.2020.101249 .
17	MOBASHERI A, RAYMAN M P, GUALILLO O, et al. The role of metabolism in the pathogenesis of osteoarthritis[J]. Nat Rev Rheumatol, 2017, 13(5):302-311. DOI: 10.1038/nrrheum.2017.50 .
18	朱璐丹. 秦皮素对嗜水气单胞菌的抗感染机制研究[D].上海:上海海洋大学, 2020. DOI: 10.27314 /d.cnki.gsscu. 2020.000028 .
	ZHU L D. Anti-infective mechanism of fraxetin against aeromonas hydrophila[D]. Shanghai: Shanghai Ocean University, 2020. DOI: 10.27314 /d.cnki.gsscu. 2020.000028 .
19	曹桂云, 宁波, 秦金淼, 等. 基于标准汤剂的秦皮(白蜡树)配方颗粒质量标准分析[J/OL]. 中国实验方剂学杂志:1-11(2022-11-22)[2023-02-22]. .
	CAO G Y, NING B, QIN J M, et al. Quality standard analysis of fraxinus fraxinus dispensing granules based on standard decoction[J/OL]. Chin J Exp Formul: 1-11(2022-11-22)[2023-02-22]. .
21	WU R, CHEN F, WANG N, et al. ACOD1 in immunometabolism and disease[J]. Cell Mol Immunol, 2020, 17(8):822-833. DOI: 10.1038/s41423-020-0489-5 .
22	GRIFFIN T M, SCANZELLO C R. Innate inflammation and synovial macrophages in osteoarthritis pathophysiology[J]. Clin Exp Rheumatol, 2019, 37 Suppl 120(5):57-63.
23	RU L B. Synovium and the innate inflammatory network in osteoarthritis progression[J]. Curr Rheumatol Rep, 2013, 15(5):323. DOI: 10.1007/s11926-013-0323-5 .
24	XIA Y, LIU N, XIE X X, et al. The macrophage-specific V-ATPase subunit ATP6V0D2 restricts inflammasome activation and bacterial infection by facilitating autophagosome-lysosome fusion[J]. Autophagy, 2019, 15(6):960-975. DOI: 10.1080/15548627.2019.1569916 .

差异Difference	基因Gene	log2FC	P值P value	校正P值P_adj value
上调Up-regulated	Mmp12	9.933 625 864	9.132 91×10^-11	3.537 83×10^-9
	Acod1	9.272 106 280	0.000 127 507	0.000 802 842
	Col2a1	9.153 847 197	7.690 69×10^-9	1.807 62×10^-7
	Atp6v0d2	8.282 894 807	5.603 80×10^-6	5.607 99×10^-5
	Fbn2	7.973 227 345	2.921 38×10^-37	3.387 43×10^-34
	Acan	7.718 643 189	4.203 11×10^-20	1.015 34×10^-17
	Ocstamp	7.591 893 578	0.001 876 497	0.007 726 778
	LOC103690326	7.546 217 455	7.903 40×10^-5	0.000 529 726
	Cxcl2	7.422 908 965	1.713 86×10^-5	0.000 145 198
	Mmp9	7.188 248 072	2.374 04×10^-11	1.027 150×10^-9
下调Down-regulated	Plekha2	-1.000 555 825	1.696 39×10^-5	0.000 143 999
	Nudt7	-1.001 123 965	5.602 09×10^-5	0.000 395 268
	Cdc42bpg	-1.002 206 901	0.000 106 010	0.000 684 033
	Mtus1	-1.002 219 197	0.000 139 053	0.000 863 768
	Ppp1r37	-1.002 289 468	4.948 870×10^-20	1.179 120×10^-17
	Oard1	-1.003 517 453	0.000 375 535	0.002 019 066

差异Difference	基因Gene	log2FC	P值P value	校正P值P_adj value
上调Up-regulated	Mmp12	9.933 625 864	9.132 91×10^-11	3.537 83×10^-9
	Acod1	9.272 106 280	0.000 127 507	0.000 802 842
	Col2a1	9.153 847 197	7.690 69×10^-9	1.807 62×10^-7
	Atp6v0d2	8.282 894 807	5.603 80×10^-6	5.607 99×10^-5
	Fbn2	7.973 227 345	2.921 38×10^-37	3.387 43×10^-34
	Acan	7.718 643 189	4.203 11×10^-20	1.015 34×10^-17
	Ocstamp	7.591 893 578	0.001 876 497	0.007 726 778
	LOC103690326	7.546 217 455	7.903 40×10^-5	0.000 529 726
	Cxcl2	7.422 908 965	1.713 86×10^-5	0.000 145 198
	Mmp9	7.188 248 072	2.374 04×10^-11	1.027 150×10^-9
下调Down-regulated	Plekha2	-1.000 555 825	1.696 39×10^-5	0.000 143 999
	Nudt7	-1.001 123 965	5.602 09×10^-5	0.000 395 268
	Cdc42bpg	-1.002 206 901	0.000 106 010	0.000 684 033
	Mtus1	-1.002 219 197	0.000 139 053	0.000 863 768
	Ppp1r37	-1.002 289 468	4.948 870×10^-20	1.179 120×10^-17
	Oard1	-1.003 517 453	0.000 375 535	0.002 019 066

[1]	LIU Zhiwei, YANG Ran, LIAN Hao, ZHANG Yu, JIN Lilun. Cartilage Protection and Anti-Inflammatory Effects of Fraxetin on Monosodium Iodoacetate-Induced Rat Model of Osteoarthritis [J]. Laboratory Animal and Comparative Medicine, 2025, 45(3): 259-268.
[2]	XU Qiuyu, YAN Guofeng, FU Li, FAN Wenhua, ZHOU Jing, ZHU Lian, QIU Shuwen, ZHANG Jie, WU Ling. A Mouse Model of Polycystic Ovary Syndrome Established Through Subcutaneous Administration of Letrozole Sustained-Release Pellets and Hepatic Transcriptome Analysis [J]. Laboratory Animal and Comparative Medicine, 2025, 45(2): 119-129.
[3]	SUN Xiaorong, SU Dan, GUI Wenjuan, CHEN Yue. Establishment and Evaluation of a Moderate-to-Severe Knee Osteoarthritis Model in Rats Induced by Surgery [J]. Laboratory Animal and Comparative Medicine, 2024, 44(6): 597-604.
[4]	QI Longju, CHEN Shiyuan, LIAO Zehua, SHI Yuanhu, SUN Yuyu, WANG Qinghua. Transcriptomic Analysis of Menstrual Blood-Derived Stem Cells Transplantation Combined with Exercise Training in Promoting Spinal Cord Injury Recovery in Rats [J]. Laboratory Animal and Comparative Medicine, 2024, 44(5): 531-542.
[5]	Ruolin CUI, Qing WANG, Ling YANG, Wenchang FENG, Zhiwei LIU, Weiran TENG, Bitao MA, Leyang WANG, Liping QIN, Lilun JIN. Repair Effects of Xiaoyusan New Formula on Cartilage Injury and MMP-13 Expression in Knee Osteoarthritis Model Rabbits [J]. Laboratory Animal and Comparative Medicine, 2023, 43(1): 30-38.
[6]	XIA Mengxiong, HAN Haihui, LIANG Qianqian, ZHAI Weitao, XU Hao. Research Progress on Animal Models of Osteoarthritis [J]. Laboratory Animal and Comparative Medicine, 2020, 40(2): 159-165.
[7]	XIAO Kunlin, ZHANG Rui, Sun Hong, XIAO Kuntai, MA Jianbing. Evaluation of Monoiodoacetic Acid-induced Knee Osteoarthritis SD Rats with Diseasse Progression at Different Time Points [J]. Laboratory Animal and Comparative Medicine, 2020, 40(1): 47-52.